Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Posting for a new COO and Clinical Trial Coordinator

<< Previous

Bullboard Posts

Next >>

Comment by Pandoraon Aug 04, 2021 1:11pm

214 Views

Post# 33648834

RE:RE:Posting for a new COO and Clinical Trial Coordinator

tamarindo1 wrote: Chief Operating Officer appears to be for the Cool Laser Therapy Div.
Both positions have advertised starting time as

21-09-07

"Chief Operating Officer (COO)

Theralase Technologies Inc. - Toronto, ON

$250,000 a year

The Anti-Cancer Therapy (“*ACT*”) division, which is a clinical stage, pre-commercialization research and development division dedicated to the research and…"

When it says it is for the Anti-Cancer Therapy Division how does that sound like it is for the Cool Laser Therapy Division -- that analysis confuses me.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing